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Qualitative studyObjective: There is a wide range of strategies that could help in minimizing medication errors during
healthcare delivery. We undertook a qualitative study to identify recommended solutions to minimize
medication errors in an adult oncology department in Saudi Arabia from the perspectives of healthcare
professionals.
Methods: This was a qualitative study conducted in an adult oncology department in Saudi Arabia. After
obtaining the required ethical approvals and written consents from the participants, seven focus group
discussions were carried out for data collection. A stratified purposive sampling strategy was used to
recruit medical doctors, pharmacists, and nurses. NVivo Pro version 11 was used for data analyses.
Inductive content analysis was adopted in the coding of collected data.
Result: Our study showed that improving organizational support, staff education, and communication
could help in minimizing medication errors in the adult oncology department.
Conclusion: The adoption of multiple strategies is required to improve the safety of the medication pro-
cess in the adult oncology department. We argue that the availability of supportive leadership should be
prioritized as it plays a crucial role in determining the effectiveness and efficiency of both staff education
and communication.
 2019 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Medication errors are a persistent problem in many healthcare
settings (Tshiamo et al., 2015). Medication errors can lead to seri-
ous consequences for both patients and healthcare organisations.
For example, in the United States, more than 7,000 deaths per year
occur due to medication errors (Anderson and Townsend, 2010).
Moreover, medication errors can lead to hospital admissions
(Assiri et al., 2018) and prolonged hospital stays; hence impactingnegatively on healthcare expenditure as well as patient outcomes
(Wittich et al., 2014).
The knowledge that half of the medication errors encountered
during hospitalisation are avoidable (Kongkaew et al., 2013) means
that there is much focus on identifying and implementing strate-
gies to minimize medication errors. The focus of these strategies
differs in terms of stage of the medication process, from prescrip-
tion to administration (e.g. electronic prescribing and comput-
erised physician order entry with clinical decision support
systems, barcodes to track medications, interventions to reduce
medication errors, medication error reporting systems) (Riaz
et al., 2017). The views of healthcare professionals as to what
may help improve medication safety have been sought in several
studies (Jones and Treiber, 2010; Cunningham, 2012; Aljadhey
et al., 2014). Consultations with healthcare professionals, espe-
cially those who are involved in medication process (prescribing,
transcribing, dispensing and administering), have aimed to identify
and implement practical solutions to address error and encourage
healthcare professionals to work in a safety-promoting environ-
ment (Health And Safety Executive, 2014). Yet, although medica-
tion error is a major issue in Gulf countries (Alsaidan et al.,
W. Alharbi et al. / Saudi Pharmaceutical Journal 27 (2019) 650–654 6512018), there have been few studies looking at how to address med-
ication error and patient safety in this context. To the best of our
knowledge, there was only one Saudi Arabian study to date which
considered the diversity of healthcare professionals’ backgrounds
on medication safety and included participants from government
hospitals, private hospitals, academia, pharmaceutical industries
and the Ministry of Health (Aljadhey et al., 2014). This study
revealed that factors contributed to medication safety include
unrestricted public access to medications, lack of communication
between healthcare institutions, limited use of technologies, and
lack of medication safety programs healthcare institutions. In con-
trast, the study we report here is situated in an adult oncology con-
text where low index medication needs to be precisely prescribed,
dispensed and administered (Ulas et al., 2015).
In an attempt to recommend improvements in medication
safety in an adult oncology setting in Saudi Arabia, we conducted
a survey-based study to evaluate patient safety culture among
healthcare professionals working in this context (Alharbi et al.,
2018). This study showed that teamwork across units, non-
punitive response to error, handoffs and transition, communication
openness, staffing, supervisors’/ managers’ expectations and
actions promoting patient safety, management support for patient
safety and overall perception of patient safety need to be strongly
considered in addressing error. Following this survey, we carried
out a qualitative study in the same setting in order to explore
healthcare professionals’ perceptions of medication errors
(Alharbi et al., 2019). We found that our participants perceived
teamwork, staffing, the handover of medication-related informa-
tion, accepted behavioural norms (e.g. fear of shame and normalis-
ing errors and near misses), the frequency of reported events, and
non-punitive response to error as leading causes of medication
errors in the adult oncology department. Following these two stud-
ies, the next step in recommending interventions to address med-
ication error was to ask the healthcare staff to identify appropriate
solutions to minimize medication errors in their workplace. The
aim of this third study was to identify recommended solutions to
minimize medication errors in an adult oncology department in
Saudi Arabia from the perspectives of healthcare professionals.2. Methods
2.1. Study setting and design
This qualitative study was conducted in the adult oncology
department of a public hospital in Saudi Arabia. We conducted
focus group discussions to provide insight into participants’ shared
appropriate solutions to minimize medication error (Savin-Baden
and Major, 2013). Using of focus group discussion offered opportu-
nity to generate data through discussion among participants to
share their knowledge and opinions to obtain solutions to mini-
mize medication errors in the department (Hays and Singh,
2011). The discussion topic guides were informed by findings of
our two previous studies (Alharbi et al., 2018; Alharbi et al.,
2019) and related literature (Al-Dhawailie, 2011; Almutary and
Lewis, 2012; Aljadhey et al., 2014). Questions included, which area
we should focus on for minimizing medication errors in the depart-Table 1
An example of the coding process (Based on Graneheim, Lundman 2004).
Meaning unit
‘‘We can increase the number of staff, but we have limited space. You can’t have 20
pharmacists in one area”.
‘‘Using of stimulation is going to give the healthcare professionals more confidence in
all medication administration processes”.ment? How will we know if a change has been effective? How
might these be changed?
2.2. Ethical considerations
The study was ethically approved by the institutional review
board. Prior to starting the focus group discussions, an information
sheet including a description of this study and participant right to
withdraw was provided to potential participants. Written consent
was obtained from each participant for participation in the focus
group discussions and audio-recording. The collected data was
only accessed by the authors to maintain confidentiality.
2.3. Sampling and recruitment
After obtaining ethical approval, we sent an explanatory email
incorporating findings from the previous two studies to the medi-
cal director and the heads of doctors, pharmacists, and nurses
within the adult oncology department inviting them to encourage
staff to participate in the study. A stratified purposive sampling
strategy was used to recruit medical doctors, pharmacists, and
nurses who were involved either in prescription, preparation or
administration of medication in the adult oncology department
(Hays and Singh, 2011). To ensure confidentiality and openness,
the researcher (WH) approached each healthcare provider individ-
ually to invite them to participate in the study. We intended to use
single profession focus groups to improve the openness and trans-
parency of discussion and encourage participants to share their
views freely (Ritchie et al., 2013). The place and time of the focus
group discussions were selected based on participant preference.
2.4. Data generation
Each focus group meeting was facilitated by the first author
(WH) and started with 10 min presentation to introduce causes
of medication errors identified in the two previous studies
(Alharbi et al., 2018; Alharbi et al., 2019). Following the presenta-
tion, discussion about strategies to minimize medication errors
was carried out. All focus group discussions were recorded and
then transcribed verbatim. Focus group discussions were con-
ducted in July 2018, in English. The average length focus group dis-
cussion was approximately 45 min. Data collection ended when no
new themes were identified in the data set.
2.5. Data coding and analysis
All transcripts were anonymised then exported into qualitative
data analysis software (NVivo Pro version 11) for coding and anal-
ysis. Each transcript was read several times by the first author
(WH) to obtain the sense of the whole. Sections in the transcripts
which were found to be linked with the study aim were selected
as meaning units. According to Graneheim and Lundman (2004),
meaning unit defined as ‘‘words, sentences or paragraphs containing
aspects related to each other through their content and context”
(Graneheim and Lundman, 2004). The meaning units were con-
densed and then labelled. The labels were then sorted into cate-
gories and sub-categories based on the manifest (explicitCondensed meaning unit Code Sub-theme Theme
Limited space to have more
staff.
Limited
Space
Improve
Staffing
Improve
Communication
Staff would gain more
confidence by simulation.
simulation Adoption of
simulation
Staff education
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Coding and categorization were discussed frequently within the
research team (WH, JC, and ZM) to check the relevance and appro-
priateness of the codes and categories.
3. Results
3.1. Participant characteristics
Twenty-seven healthcare professionals participated in seven
single-profession focus groups. Of the 27 participants, 16 were
nurses, eight were doctors, and three were pharmacists. Female
healthcare professionals formed the majority of participants
(63%). Most participants were not of Saudi nationality (88.9%).
The overall average participants’ age was 35 years old.
3.2. Main themes
Our study revealed three broad recommended areas to mini-
mize medication errors in the adult oncology department. These
themes are discussed here and include organizational support, staff
education, and improving communication.
3.2.1. Organizational support
The majority of participants mentioned that organizational sup-
port was important in minimizing medication errors. Examples
included more supportive policies and leadership for patient safety
in general and medication errors in particular.
3.2.1.1. Supportive policies. Participants, most particularly rotating
doctors, stated that medication prescriptions policies should be
unified in all over the hospital’s departments. This would help in
avoiding errors in prescriptions and delays in dispensing: ‘‘We
should have a prescription policy that is applied similarly in all depart-
ments in this hospital to make writing prescriptions safer” (Medical
doctor 2, Focus Group 5). Moreover, the analysis indicated a need
to develop a policy that supports free blame and shame culture.
In addition, all levels of management should be familiar with it
‘‘All supervisors and heads should have a clear policy from the hospital
management to have free blame and shame culture” (Nurse 4, Focus
Group 3).
3.2.1.2. Supportive leadership. Most Participants believed that
department leadership could play a key role in minimizingmedica-
tion errors. From their perspectives, they should be more support-
ive to non-blame culture as this would improve reporting of errors
in this department ‘‘higher authority must create that culture
wherein the nurses will not be fear of informing those are medication
error so that they can have trained more to the nurses” (Nurse 2, Focus
Group 1). Such a leadership attitude could be further enhanced by
more involvement in courses to achieve a more supportive man-
agerial approach to dealing with errors as they occur ‘‘I think we
should contact the managers, we need to train the managers how to
deal with the healthcare providers who did a medication error” (Phar-
macists 2, Focus Group 7).
3.2.2. Staff education
Participants indicated that providing proper education would
help in minimizing medication errors. Education could be
improved by the increased use of simulation and training courses.
3.2.2.1. Adoption of simulation. Participants’ responses indicated
that using simulation as an educational approach would help
improve their technical skills in a zero harm environment. This
would help them to gain more self-confidence in clinical practice:‘‘using of stimulation is going to give the healthcare professionals more
confidence in all medication administration processes” (Pharmacist 3,
Focus Group 7). Moreover, frequent simulation sessions have the
potential to improve non-technical skills, particularly communica-
tion between team members: ‘‘We can utilize the simulation centre
here to have training sessions to improve our communication, and it
must be attended from all the healthcare professionals” (Nurse, Focus
Group 2).
3.2.2.2. Frequent training. Participants mentioned that frequent
training sessions would help improve their knowledge about com-
mon medication errors in the department and ways to avoid the
occurrence of such errors: ‘‘we need more educational sessions and
discussions about the common medication errors in the department
actually. This would help very much if it held every week” (Medical
doctor 2, Focus Group 6). Frequent education sessions would be use-
ful in raising the awareness of newly employed staff and juniors on
medication safety-related issues: ‘‘I suggest to do frequent short one
or two days intensive course to educate the new staff what kind of
chemotherapy since the oncology department is totally different from
others in medication preparation.” (Medical doctor 1, Focus Group 6).
3.2.2.3. Improving communication. In this department, communica-
tion between healthcare providers could be improved by more fre-
quent meetings, more supportive technology and improved
staffing.
3.2.2.4. Frequent meetings. Participants showed concern about the
frequency of meetings in the department. They felt the need to
have more multi-disciplinary meetings to discuss factors hindering
the medication management process: ‘‘We have to make good com-
munication between our staff and our heads of departments by doing
periodic meetings inside the department” (Medical doctor 1, Focus
Group 6).
3.2.2.5. Use of technology. Most participants assumed that using
electronic prescription systems would help to minimize medica-
tion error. They indicated this would improve and facilitate pre-
scribing, save time, and improve communication by producing
more legible prescriptions: ‘‘electronic prescription I believe is better,
it is really better, it will decrease the workload, wasting time, and the
miscommunication between doctors, pharmacists, and nurses” (Nurse
4, Focus Group 1).
3.2.2.5.1. Improved staffing. The majority of participants
believed that staff work overload was a serious barrier to effective
communication as they did not have enough time to communicate
properly. This overload occurred as a consequence of the shortage
of staff compared to the increasing number of admitted patients
and limited spaces in the department’s facilities: ‘‘The staff are leav-
ing. There is raining going on. The last three years we never saw any
recruitment going” (Medical doctor 1, Focus Group 5). Accordingly,
participants proposed that the management should increase staff
recruitment of staff of suitable quality to meet the clinical stan-
dards. It was accepted that the departmental accommodation
was a limitation to increased staffing, requiring the expansion
and renovation of the department’s facilities.
4. Discussion
To the best of our knowledge, this is the first qualitative study in
Saudi Arabia to address strategies to minimize medication errors in
an adult oncology department from the perspectives of a variety of
healthcare professionals (doctors, pharmacists, and nurses). The
findings of this study suggest that improving organizational sup-
port, staff education and communication between the staff would
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ings suggest that, of the proposed strategies mentioned above,
organizational support for patient safety forms a cornerstone in
improving medication safety in the department. In particular, lead-
ership plays a vital role in determining the effectiveness and effi-
ciency of both staff education and communication, both of which
would impact positively on the medication process.
The vital role of leadership in promoting safe healthcare prac-
tices has been emphasised by many well-recognized healthcare
bodies (e.g. The Health Foundation and Agency for Healthcare
Research and Quality [AHRQ]) (Leonard and Frankel, 2012; AHRQ,
2018). They highlighted the importance of leadership in establish-
ing high-performing health systems that minimize adverse events
(Leonard and Frankel, 2012; AHRQ, 2018). Additionally, healthcare
organizations with dedicated leadership would have a culture that
encourages learning from errors, supports teamwork, and exploits
organizational resources for improving patient safety (Baker,
2011).
However, to achieve this, leadership should demonstrate a com-
mitment to patient safety by engaging themselves in patient safety
processes (e.g. leadership safety walk rounds) (Frankel et al., 2003).
They should prioritise patient safety during the development of
policies and procedures (Scheffler and Zipperer, 1999). Moreover,
they should promote openness by adopting a non-punitive
approach in managing adverse events, and consider the views of
frontline staff members for quality and safety improvement
(Elmqvist et al., 2016).
Besides leadership commitment, the provision of appropriate
staff education and training, as indicated by participants in this
study, have been shown to impact positively on medication safety.
For example, Daupin and his colleges (2016) conducted a study to
find out whether healthcare professionals are able to identify risks
related to medication process by using simulation in a mother and
child healthcare setting in Canada. Most participants (97.8%) in this
study indicated that adopting simulation as an educational
approach was effective in identifying risky practices and that they
would change their medication-related practice in light of the sim-
ulation results (Daupin et al., 2016).
As mentioned in the above example, the provision of staff train-
ing has the potential to improve technical skills related to medica-
tion practice. In addition, staff training could have a significant
positive impact on the non-technical side of the medication pro-
cess as well. For example, it was revealed by a study conducted
in Blackpool Victoria hospital simulation unit in the UK that simu-
lation session helped in improving participants’ non-technical
skills (communication and teamwork) with a statistically signifi-
cant difference between pre- and post-course mean scores
(p = 0.0314) (Gordon et al., 2015).
This study had strengths and limitations. In terms of limitations,
patients were not involved in this study. Patients have valid points
of view which should be considered in research conducted in this
context (Schwappach and Wernli, 2010). Moreover, this study
was conducted in one department, and therefore the findings can-
not be generalizable (Guba and Lincoln, 1994). On the other hand,
this study was the first qualitative study to address strategies that
could minimize medication errors in an adult oncology depart-
ment. In addition, we highly considered the multi-disciplinary nat-
ure of care in the oncology department; therefore, we included
participants from a variety of disciplines who are involved in the
medication process.
The findings of this study have a number of implications related
to future research, policy-making and practice. This study pro-
posed strategies which would theoretically minimize medication
errors in the Saudi oncology setting; therefore, future research
should strongly consider interventional approaches to evaluate
the effectiveness of the abovementioned strategies in the adultoncology department. With regard to policy making, policies and
procedures should be developed for key medication processes
and standardized in order to avoid medication-related errors
resulting from staff confusion and to reduce discrepancies in med-
ication practices (Irving, 2014). In addition, healthcare managers
and leaders have to maintain staff competency through the provi-
sion of continuous training and education (Gesme et al., 2010).
They must also promote openness in the workplace to encourage
staff to raise patient safety issues and learn from errors
(Campione and Famolaro, 2018).
5. Conclusion
The adoption of multiple strategies is required to improve the
safety of the medication process in the adult oncology department.
Those strategies should address organizational support, training
and education, as well as communication between staff. We argue
that the availability of supportive leadership should be prioritized
as it plays a crucial role in determining the effectiveness and effi-
ciency of both staff education and communication, both of which
would impact positively on the safety of the medication process.References
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